Identification of DYRK2 and TRIM32 as keloids programmed cell death-related biomarkers: insights from bioinformatics and machine learning in multiple cohorts
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study identifies DYRK2 and TRIM32 as key genes for keloid diagnosis and explores their mechanisms. SB-431542 emerges as a potential therapeutic agent for keloid treatment.
Area Of Science
- Biomedical Research
- Molecular Biology
- Dermatology
Background
- Keloids are abnormal scars resulting from dysregulated wound healing.
- Understanding the molecular mechanisms of keloid development is crucial for effective treatment strategies.
Purpose Of The Study
- To investigate the expression patterns of programmed cell death-related genes in keloids.
- To identify novel molecular targets for the early diagnosis and treatment of keloids.
Main Methods
- Machine learning algorithms were employed to identify key genes from keloid expression data.
- Gene Set Enrichment Analysis (GSEA), immune cell profiling, and competing endogenous RNA (ceRNA) network construction were utilized.
- Single-cell analysis, Connectivity Map (CMap), and molecular docking were performed to elucidate mechanisms and identify therapeutic agents.
Main Results
- DYRK2 and TRIM32 were identified as key diagnostic genes for keloids, with significant diagnostic potential shown by ROC curves.
- The study revealed the mechanism of action and regulatory network of DYRK2 and TRIM32 in keloids.
- SB-431542 was identified as a potential therapeutic agent for keloid treatment.
Conclusions
- DYRK2 and TRIM32 are promising molecular targets for keloid diagnosis.
- Further research into the identified mechanisms and the therapeutic potential of SB-431542 could lead to improved keloid management.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.